Costa Rica vs Naoero: New cases tested for RR-/MDR-TB
Costa Rica
100.0%
in 2024
Naoero
100.0%
in 2023
Costa Rica rank
1st
Naoero rank
1st
New cases tested for RR-/MDR-TB over time
- Costa Rica
- Naoero
How they compare
Costa Rica currently reports 100.0% against 100.0% in Naoero, a difference of 0.0%.
The two have swapped places 3 times across 9 shared years of data; in 2011 it was Costa Rica ahead.
Costa Rica ranks 1st and Naoero ranks 1st of 192 countries.
Across the 2 decades both report, Costa Rica averaged higher in 1 and Naoero in 1.
Head to head by decade
| Decade | Costa Rica | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.1% | 0.0% | 51.1% | Costa Rica |
| 2020s | 61.0% | 100.0% | 39.0% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Costa Rica or Naoero?
- Costa Rica, at 100.0% against 100.0% in Naoero as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Costa Rica and Naoero?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Naoero?
- 9 years are reported by both, from 2011 to 2023.
- How do Costa Rica and Naoero rank globally for new cases tested for rr-/mdr-tb?
- Costa Rica ranks 1st and Naoero ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.